Product
Lapatinib Ditosylate
1 clinical trial
2 indications
Indication
Metastatic Thyroid CancerIndication
Thyroid CancerClinical trial
A Phase 1 Study of Dabrafenib in Combination With Lapatinib in BRAF Mutant Thyroid CancerStatus: Active (not recruiting), Estimated PCD: 2024-12-01